Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 11, 2015

Primary Completion Date

December 11, 2019

Study Completion Date

December 11, 2019

Conditions
Pompe Disease
Interventions
OTHER

Blood sample

A blood sample for CPK dosage and pompe disease test

Trial Locations (21)

29609

CHU de Brest, Brest

37044

CHRU de Tours, Tours

49800

Clinique Saint Joseph, Trélazé

94000

CHI de Créteil, Créteil

CHU de St Etienne, Saint-Etienne

Unknown

CHU d'Angers, Angers

Centre hospitalier d'Argenteuil, Argenteuil

CH d'Escartons, Briançon

CH de Cannes, Cannes

CHU le Bocage, Dijon

CHRU de Lille, Lille

CHU de Limoges, Limoges

Cabinet Dr Pereira-Cortese, Nice

CHU de Nice, Nice

GH Pitié Salpêtrière, Paris

Hôpital Raymond Poincaré, Paris

Hôpital Saint Louis, Paris

Hôpital Tenon, Paris

Polyclinique les Bleuets, Reims

CHU de Rouen, Rouen

CHU de Toulouse, Toulouse

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02746718 - Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness | Biotech Hunter | Biotech Hunter